Literature DB >> 11926135

Use of HSV vectors to modify the nervous system.

Joseph C Glorioso1, David J Fink.   

Abstract

Herpes simplex virus (HSV) is a natural human pathogen that efficiently infects sensory neurons to establish a life-long latent state. Recombinant replication-defective vectors, created by disruption of critical viral gene functions, nonetheless target neurons and can be used to express transgenes to alter the structure and/or function of the nervous system. Specific applications of these vectors to models of neurodegeneration (Parkinson's disease), trauma (spinal root avulsion), peripheral neuropathy and neuronal function (pain) have been published within the last year. With these applications and the clinical experience in human tumor trials with HSV vectors, the stage is set for the use of HSV-based vectors to treat neurologic disease in humans in the near future.

Entities:  

Mesh:

Year:  2002        PMID: 11926135

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  4 in total

1.  Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.

Authors:  Benjamin Storek; Matthias Reinhardt; Cheng Wang; William G M Janssen; Nina M Harder; Michaela S Banck; John H Morrison; Andreas S Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

2.  Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle.

Authors:  Hui Zheng; Chunping Qiao; Chi-Hsien Wang; Juan Li; Jianbin Li; Zhenhua Yuan; Cheng Zhang; Xiao Xiao
Journal:  Hum Gene Ther       Date:  2010-01       Impact factor: 5.695

3.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.

Authors:  D Perkins; E F R Pereira; L Aurelian
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats.

Authors:  Benjamin Storek; Nina M Harder; Michaela S Banck; Cheng Wang; Douglas M McCarty; William Gm Janssen; John H Morrison; Christopher E Walsh; Andreas S Beutler
Journal:  Mol Pain       Date:  2006-01-30       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.